Global Heart Pump Devices Market to Progress at a Substantial CAGR of 15.16%, Reaching Almost USD 6.3 billion by 2027, Asserts DelveInsight

2022-07-20
PRNewswire
The demand for Heart Pump Devices is primarily attributed to factors such as the rising prevalence of cardiovascular diseases, increased time duration pertaining to heart transplants, and the entrance of key companies such as Abbott Laboratories, Abiomed, Inc., Teleflex Incorporated, SynCardia Systems, LLC, St. Jude Medical Inc., and others in the market. These all factors are directly related to the growth of the Heart Pump Devices market.
LAS VEGAS, July 20, 2022 /PRNewswire/ -- DelveInsight's
Heart Pump Devices Market Insights and Forecast report provides the current and forecast Heart Pump Devices Market, upcoming innovations in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Heart Pump Devices Market.
Some of the essential takeaways from the
Heart Pump Devices Market report
:
As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Heart Pump Devices market.
Some of the Global Heart Pump Devices Device companies with access devices in various stages of development include
DelveInsight analysis states that the Global Heart Pump Devices Market was valued at
USD  2.73 Billion in 2021, growing at a
CAGR of 15.16% during the forecast period from 2021 to 2027 to reach
USD 6.35 Billion by 2027.
In
August 2021, the United States FDA granted breakthrough device designation to
Abiomed's Impella ECP expandable percutaneous Heart Pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes, including design iterations, clinical study protocols, and pre-market approval (PMA) application.
On
June 30, 2021, Abiomed's heart pump
Impella RP with SmartAssist technology received the United States FDA pre-market approval.
In
February 2021, CARMAT received FDA approval to conduct an Early Feasibility Study (EFS) of its
Total Artificial Heart in the US using
BlueSync technology.
In
December 2020, Abbott received FDA approval for the updated labeling for the
HeartMate 3 Heart Pump to be used in pediatric patients with advanced refractory left ventricular heart failure.
On
February 04, 2020, Abbott received the Food and Drug Administration's Breakthrough device designation for its
Fully Implantable Left Ventricular Assist System (FILVAS), currently under the process of development.
On
February 11, 2019, Leviticus Cardio and
Jarvik Heart unveiled the use of the first FIVAD device for wireless power implanted in humans in Kazakhstan. The device uses coplanar energy transfer for wirelessly providing power to the heart pump, also known as the Ventricular Assist Device (VAD). Thus, owing to such development as product launches, there will be significant growth observed in the Heart Pump Devices market during the forecast period.
To pick on the latest highlights related to the Heart Pump Devices implantable device market, get a snapshot of the key highlights entailed in the
Heart Pump Devices Market Sample Report
Heart Pump Devices Overview
Heart failure is a condition wherein the heart is not able to pump an adequate amount of blood to meet the requirements of the body. The cause of heart failure depends on several factors such as pre-myocardial infarction (heart attack), high blood pressure, heart diseases, atrial fibrillation, and others such as a coronary artery. In order to help cardiac circulation, several types of cardiovascular pumping systems are available in the market. The devices are surgically implanted and used in humans suffering from low heart.
Heart Pump Devices Market Insight
Geographically, the Global Heart Pump Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. Regarding revenue, North America accounts for the highest revenue share compared with the Global Heart Pump Devices market, which will remain constant during the forecast period. However, the domination of North America will be conspicuously challenged by the European market. This domination is attributed to the increased cardiovascular disease prevalence in the region, the rising number of regulatory approvals, and the favorable refund scheme.
Various  Heart Pump Devices market growth opportunities can also be witnessed for other countries, including European countries owing to the rising number of patients suffering from cardiovascular disease and the recent launch of new products in this region.
Moreover, the regional companies are increasing their manufacturing of essential medical device products. For instance, in
August 2021, the United States Food and Drug Administration (FDA) has granted breakthrough device designation to
Abiomed's Impella ECP expandable percutaneous Heart Pump. The designation means the FDA will prioritize Impella ECP's regulatory review processes including design iterations, clinical study protocols, and pre-market approval (PMA) application.
Click here to understand more about the key players in the Heart Pump Devices Market and their future @
Heart Pump Devices Future Assessment
Heart Pump Devices Market Dynamics
The major factors driving the demand for Heart Pump Devices are the
increasing prevalence of cardiovascular diseases, the rising geriatric population, technology advances, new product development by the Heart Pump Devices market players. Heart Pump devices were found to be
extremely beneficial in heart failure cases in COVID-19, which further pushed the demand for these devices during the pandemic situation. Due to a
scarcity of heart suppliers, cardiac pumps are an optimal solution that encourages Global market expansion.
On the contrary, factors such as the
high cost of the pump and a low repayment scenario in developing countries are nevertheless projected to inhibit the growth of the Heart Pump Devices market.
COVID-19 pandemic has been observed to be an incomparable public health emergency that has affected almost every industry, and its long-term effects of it are projected to impact the healthcare market. As for the Heart Pump Devices market, they had observed a period of slow growth because of
heart pump device stock-outs, unavailability of the heart pump devices, and closed clinics.
However, the manufacturing companies and clinics are slowly resuming their operations. Patient visits are also gradually increasing after the relaxation given as per the new lockdown guidelines. There is still an increasing amount of research going on regarding the use of Heart Pump Devices in COVID-19 patients. Hence, the devices are slowly gaining normalcy regarding Heart Pump Devices market growth.
To gain a better understanding of the COVID-19 impact on Heart Pump Devices, get a snapshot of the
COVID-19 Impact on the Heart Pump Devices Market
Scope of the
Heart Pump Devices Market Report
Coverage
: Global
Study Period: 2019-2027
Market Segmentation By Product - Ventricular Assist Devices- Left Ventricular Assist Devices (LVAD), Percutaneous Ventricular Assist Devices (PVAD), Biventricular Ventricular Assist Devices (BIVAD), Right Ventricular Assist Devices (RVAD), and Intra-Aortic Balloon Pumps, Total Artificial Hearts
Market Segmentation By Type - Implanted Heart Pump Device, Extracorporeal Heart Pump Device
Market Segmentation By Therapy - Bridge-To-Transplant (BTT), Bridge-To-Candidacy (BTC), Destination Therapy (DT)
Market Segmentation By End-User - Hospitals, Cardiac Centres, Ambulatory Surgical Centres
Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of the   World
Product Profiles,
Case Studies, KOL's Views, Analyst's View
Delveinsight Analysis: The Global Heart Pump Devices Market size was valued at
USD 2.73 Billion in
2021, growing at a
CAGR of 15.16% during the forecast period from 2022 to 2027, to reach
USD 6.35 Billion by
2027.
Know more about which MedTech player is set to emerge as the trendsetter in the Global Heart Pump Devices Market @
Key Heart Pump Devices Companies Analysis
Table of Contents
Learn more about the Heart Pump Devices
@
Heart Pump Devices Regulatory Landscape
Related Reports
Cardiac Valvulotome Market
"DelveInsight's
'Cardiac Valvulotome Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Valvulotome and the historical and forecasted Cardiac Valvulotome market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Braun Melsungen AG, LeMaitre Vascular, Inc., Andramed GmbH,BD., InvaMed, Koven Technology Canada Inc, and others.
Cardiac Resynchronization Therapy Market
"DelveInsight's
'Cardiac Resynchronization Therapy Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Resynchronization Therapy and the historical and forecasted Cardiac Resynchronization Therapy market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Restoration Systems Market
"DelveInsight's
'Cardiac Restoration Systems Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Restoration Systems and the historical and forecasted Cardiac Restoration Systems market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Output Monitors Market
"DelveInsight's
'Cardiac Output Monitors Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of Cardiac Output Monitors and the historical and forecasted Cardiac Output Monitors market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Monitoring Devices Market
Global Cardiac Monitoring Devices Market report delivers an in-depth understanding of Cardiac Monitoring Devices and the historical and forecasted Cardiac Monitoring Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Biomarkers Testing Market
Global Cardiac Biomarkers Testing Market report delivers an in-depth understanding of Global Cardiac Biomarkers Testing market trends, market drivers & barriers, unmet needs, and key companies involved such as
Cardiac Assist Devices Market
Global Cardiac Assist Devices Market report delivers an in-depth understanding of Global Cardiac Assist Devices and the historical and forecasted Global Cardiac Assist Devices market trends, market drivers & barriers, unmet needs, and key companies involved such as
3D Cardiac Mapping System Market
"DelveInsight's
'3D Cardiac Mapping System - Market Insight, Competitive Landscape and Market Forecast, 2027' report delivers an in-depth understanding of 3D Cardiac Mapping System and the historical and forecasted 3D Cardiac Mapping System market trends, globally, which comprises of North America, Europe, APAC, and RoW, market drivers & barriers, unmet needs, and key companies involved such as
Browse Through Our Blog Posts
Rising
Global Prevalence of Cardiovascular Diseases
And Top Players In Cardiology
With advancements in Innovative Technology,
Cardiac Monitoring Devices Market
is Booming Significantly
Mapping the Increasing Burden of Heart FailureHeart Failure
: What Does it Bring for Healthcare Market Companies?
What Factors are Shaping the Trends in the
Implantable Cardiac Monitors Market?
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Connect With Us at LinkedIn
| Facebook | Twitter
Contact Us
[email protected]
+1(919)321-6187
www.delveinsight.com
Logo: https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
更多内容，请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。
机构
适应症
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台，助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台，以API或者数据包形式对外开放，助您更加充分利用智慧芽新药情报信息。